FDA Calls for Nominations for TPSAC Members.

Sep.27.2022
FDA Calls for Nominations for TPSAC Members.
The FDA is seeking nominations for two individuals to serve on the Tobacco Products Scientific Advisory Committee.

The US Food and Drug Administration's Center for Tobacco Products is currently seeking nominations for two individuals to serve as voting members of the Tobacco Product Scientific Advisory Committee (TPSAC). According to the FDA website, individuals are able to self-nominate or be nominated by any interested person or organization.


Source: Postmodern Studio


Nominations received by November 25, 2022 or before will be given priority consideration. Nominations received after November 25, 2022 will be considered for future openings.


The Tobacco Products Scientific Advisory Committee (TPSAC) provides advice to the Center for Tobacco Products (CTP) of the U.S. Food and Drug Administration (FDA) regarding its responsibilities in regulating tobacco products. The committee reviews and evaluates tobacco product safety, dependence, and health issues, and provides appropriate recommendations, information, and advice to the FDA Commissioner.


This notice has been published in the Federal Gazette.


Disclaimer:


This article is compiled from third-party information and is intended for industry discussions and learning purposes only.


This article does not reflect the views of 2FIRSTS, nor can 2FIRSTS confirm the truthfulness and accuracy of the article's content. The translation of this article is only intended for communication and research purposes within the industry.


Due to limitations in the translator's proficiency, the translated article may not accurately convey the original meaning. Therefore, it is recommended to refer to the original article for accuracy.


In regards to any domestic, Hong Kong, Macau, Taiwan or international issues, 2FIRSTS maintains complete alignment with the Chinese government's statements and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

MK Lab CEO Offers In-Depth Analysis of Japan's E-Cigarette Market at 2Firsts Forum: Regulations, User Trends, and Marketing Strategies
MK Lab CEO Offers In-Depth Analysis of Japan's E-Cigarette Market at 2Firsts Forum: Regulations, User Trends, and Marketing Strategies
At the 2Firsts Global NGP Forum, MK Lab CEO KUNIYOSHI/MAKIO provided an in-depth analysis of Japan's e-cigarette market, examining regulatory constraints, consumer trends, and localized marketing strategies. He emphasized that viewing "product as culture" is key to overcoming regulatory and user barriers.
Jul.30 by 2FIRSTS.ai
UK Stoke-on-Trent Police Crack Down on Illegal Tobacco and Vapes, Seize Products Worth $920,000
UK Stoke-on-Trent Police Crack Down on Illegal Tobacco and Vapes, Seize Products Worth $920,000
Stoke-on-Trent authorities seized £700,000 ($920,000) in illegal tobacco and vapes from a storage unit, including 638,380 cigarettes, 108 kg of tobacco, and 1,262 vapes. The renter is under investigation. Officials warned of serious consequences for organized crime.
Aug.01 by 2FIRSTS.ai
2Firsts Exclusive: Dr. Zdinak Analyzes FDA’s Rejection of blu, Citing Lack of Behavioral Evidence
2Firsts Exclusive: Dr. Zdinak Analyzes FDA’s Rejection of blu, Citing Lack of Behavioral Evidence
In a 2Firsts exclusive, ARAC’s Dr. Zdinak explains FDA’s blu rejection stems from weak behavioral science data and urges companies to strengthen Module 6 studies immediately.
Aug.20
Juul Labs Files Lawsuit Against NJOY and Altria Over Patent Infringement
Juul Labs Files Lawsuit Against NJOY and Altria Over Patent Infringement
Juul Labs sues NJOY and Altria for patent infringement, escalating legal battle over e-cigarette technology.
Aug.11 by 2FIRSTS.ai
Kazakhstan Pavlodar region destroys illegal e-cigarettes worth over a billion tenge
Kazakhstan Pavlodar region destroys illegal e-cigarettes worth over a billion tenge
Kazakhstan's Pavlodar region destroys illegal e-cigarettes worth over one billion tenge after investigation uncovers smuggling network.
Aug.14 by 2FIRSTS.ai
Dawn-Marie Hutchinson Named Senior Vice President and Chief Information Officer at Reynolds American Inc.
Dawn-Marie Hutchinson Named Senior Vice President and Chief Information Officer at Reynolds American Inc.
Dawn-Marie Hutchinson appointed as Senior VP and CIO of Reynolds American Inc., leading tech strategy and operations effective Oct. 1, 2025.
Sep.11 by 2FIRSTS.ai